efzofitimod – Talk Bio

Actionable Insights Powered by AI

aTyr’s Steroid-Sparing Lung Disease Drug Disappoints in Late-Stage Trial

aTyr Pharma; efzofitimod; steroid-sparing; pulmonary sarcoidosis; interstitial lung disease